EP2033660 - Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 12.02.2010 Database last updated on 12.11.2024 | Most recent event Tooltip | 12.02.2010 | Application deemed to be withdrawn | published on 17.03.2010 [2010/11] | Applicant(s) | For all designated states Freie Universität Berlin Kaiserswerther Strasse 16-18 14195 Berlin / DE | For all designated states Charité - Universitätsmedizin Berlin Charitéplatz 1 10117 Berlin / DE | [N/P] |
Former [2009/11] | For all designated states Freie Universität Berlin Kaiserswerther Strasse 16-18 14195 Berlin / DE | ||
For all designated states Charité-Universitätsmedizin Berlin Charitéplatz 1 10117 Berlin / DE | Inventor(s) | 01 /
Reissig, Hans-Urlich Wulfstrasse 15 12165 Berlin / DE | 02 /
Dernedde, Jens Niebuhrstrasse 72 10629 Berlin / DE | 03 /
Schlecht, Sabine Wilhelmstrasse 5 10963 Berlin / DE | 04 /
Roskamp, Meike Bundesallee 198 10717 Berlin / DE | [2009/11] | Representative(s) | Engelhard, Markus Boehmert & Boehmert Anwaltspartnerschaft mbB Pettenkoferstrasse 22 80336 München / DE | [N/P] |
Former [2009/11] | Engelhard, Markus Forrester & Boehmert Pettenkoferstrasse 20-22 80336 München / DE | Application number, filing date | 07017412.3 | 05.09.2007 | [2009/11] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2033660 | Date: | 11.03.2009 | Language: | EN | [2009/11] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 31.03.2008 | Classification | IPC: | A61K47/48, A61P29/00, A61P17/06, A61P11/06, A61P19/02, A61P37/06, A61P37/00 | [2009/11] | CPC: |
A61K47/6923 (EP);
A61P11/06 (EP);
A61P17/06 (EP);
A61P19/02 (EP);
A61P29/00 (EP);
A61P37/00 (EP);
A61P37/06 (EP)
(-)
| Designated contracting states | [2009/47] |
Former [2009/11] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR | Title | German: | Funktionalisierte Nanopartikel zur Hemmung Selectin-vermittelter Zelladhäsion | [2009/11] | English: | Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion | [2009/11] | French: | Nanoparticules fonctionnalisées pour l'inhibition d'adhésion de cellule au moyen d'une sélection | [2009/11] | Examination procedure | 12.09.2009 | Application deemed to be withdrawn, date of legal effect [2010/11] | 20.10.2009 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2010/11] | Fees paid | Penalty fee | Additional fee for renewal fee | 30.09.2009 | 03   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO0232404 (CONSEJO SUPERIOR INVESTIGACION [ES], et al) [X] 1-12,15-19,21,22 * claims 1,15,24 * * page 3, lines 22-28 * * page 5, lines 6-12 * * page 11, line 11 - page 12, line 12 * * page 13, lines 4-14 * * page 25 - page 27 * * page 25, lines 11-13 * * page 26, lines 24-32 * * page 28, lines 15-19 * * figure 1 *; | [X]WO2006037081 (UNIV CALIFORNIA [US], et al) [X] 1-9,15-17 * page 6, paragraph 2 * * claims 11,16 * * page 24, paragraph LAST - page 25, paragraph 1; example 1 * * page 25, paragraph LAST * * page 5, paragraph 2 * * page 18, paragraph 1 * * page 20, paragraphs 1,2 *; | [X]WO0241826 (NANOSOLUTIONS GMBH [DE], et al) [X] 1-9,15,16 * page 7, line 4 - page 8, line 18 * * page 9, lines 21-26 * * page 10, lines 4-15 * * figure 3 * * page 23, lines 20-35 * * claims 6,13 *; | [A]US2005003459 (KRUTZIK SIEGFRIED RICHARD [US]) [A] 1-9,15,16 * claim 130 * * claims 142-147 * | [X] - WAYNE SPEVAK ET AL, "Carbohydrates in an acidic multivalent assembly: Nanomolar P-selectin inhibitors", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (1996), vol. 39, no. 5, ISSN 0022-2623, pages 1018 - 1020, XP002393863 [X] 1,4,5,8-13,15,17-22 * page 1018, column 1, paragraph 1 * * page 1018, column 2, paragraph 1 - page 1019, column 2, paragraph 1 * * figures 1,2 * DOI: http://dx.doi.org/10.1021/jm950914+ | [A] - YAREMA K J ET AL, "CHEMICAL APPROACHES TO GLYCOBIOLOGY AND EMERGING CARBOHYDRATE-BASED THERAPEUTIC AGENTS", CURRENT OPINION IN CHEMICAL BIOLOGY, CURRENT BIOLOGY LTD, LONDON, GB, (1998), vol. 2, no. 1, ISSN 1367-5931, pages 49 - 61, XP000979483 [A] 1-22 * page 50, column 1, paragraph LAST - page 51, column 2, paragraph 4 * DOI: http://dx.doi.org/10.1016/S1367-5931(98)80035-5 | [A] - YEKTA S ET AL, "Simple modifications of enantiopure 1,2-oxazines leading to building blocks for carbohydrate and peptide mimetics", SYNLETT 20070813 DE, (20070813), no. 13, ISSN 0936-5214, pages 2069 - 2072, XP008089227 [A] 1-22 * compound 7 * * page 2069, column 1, paragraph 1 - column 2, paragraph 1 * * page 2071, column 1, paragraph 2 * * page 2072, paragraph 19 * | [A] - KAILA N ET AL, "Selectin inhibitors", EXPERT OPINION ON THERAPEUTIC PATENTS 01 MAR 2003 UNITED KINGDOM, (20030301), vol. 13, no. 3, ISSN 1354-3776, pages 305 - 317, XP002470966 [A] 1-22 * page 307, column 1, paragraph 2 - column 2, paragraph 1 * * page 311, column 2, paragraph 3 * DOI: http://dx.doi.org/10.1517/13543776.13.3.305 | [A] - WILKINS P ET AL, "Tyrosine sulfation of P-selectin glycoprotein ligand-1 is required for high affinity binding to P-selectin", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, (19950929), vol. 270, no. 39, ISSN 0021-9258, pages 22677 - 22680, XP002111841 [A] 1-22 * page 22677, column 2, paragraph 3 * DOI: http://dx.doi.org/10.1074/jbc.270.39.22677 |